Status:
RECRUITING
Exhaled Breath Particles in Lung Transplantation
Lead Sponsor:
Lund University Hospital
Conditions:
Lung Transplant Rejection
Primary Graft Dysfunction
Eligibility:
All Genders
16-75 years
Brief Summary
Lung transplantation (LTx) is the only effective treatment for patients with end stage lung disease. Of the major organs transplanted, survival following LTx is the lowest with a mean of 5 years. Desp...
Detailed Description
Samples of EBP and measurement of PFR will be done on patients undergoing lung transplantation at Skåne University Hospital (SUS) Lund. Measurements of EBP and PFR and collection of blood will be done...
Eligibility Criteria
Inclusion
- Patients who have undergone LTx at Skåne University Hospital, SUS Lund
Exclusion
- None
Key Trial Info
Start Date :
September 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05375149
Start Date
September 18 2018
End Date
September 1 2026
Last Update
May 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skåne University Hospital
Lund, Skåne County, Sweden, 224 60